There facebook post
We’re pleased to announce the successful enrolment of 40 out of 60 patients in our IRB approved clinical trial for diabetic nerve pain.The multi-arm, head-to-head trial will evaluate the efficacy and tolerability of our proprietary medicinal cannabis product against a multi-billion dollar big pharmaceutical company drug.Half of all people with diabetes will develop neuropathy which can be incredibly challenging and impact a person’s quality of life. We expect to complete trial enrolment and provide a trial read out in Q4 2022.Read more: http://ow.ly/OY8x50KJMXK
- Forums
- ASX - By Stock
- ZLD
- Ann: ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled
Ann: ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled, page-5
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
|
|||||
Last
63.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.148M |
Open | High | Low | Value | Volume |
63.0¢ | 63.0¢ | 63.0¢ | $636 | 1.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1190 | 63.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
73.0¢ | 4489 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1190 | 0.630 |
2 | 5830 | 0.610 |
4 | 5415 | 0.600 |
1 | 8000 | 0.580 |
1 | 1200 | 0.560 |
Price($) | Vol. | No. |
---|---|---|
0.730 | 4489 | 3 |
0.760 | 3933 | 1 |
0.930 | 6000 | 1 |
0.940 | 41387 | 3 |
1.000 | 17106 | 2 |
Last trade - 13.56pm 26/07/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |